Skip NavigationSkip to Content
Return Return to Search Results

Filovirus-like particles produced in insect cells: Immunogenicity and protection in rodents

  1. Author:
    Warfield, K. L.
    Posten, N. A.
    Swenson, D. L.
    Olinger, G. G.
    Esposito, D.
    Gillette, W. K.
    Hopkins, R. F.
    Costantino, J.
    Panchal, R. G.
    Hartley, J. L.
    Aman, M. J.
    Bavari, S.

  2. Author Address

    USA, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA. NCI, Sci Applicat Int Corp, Prot Express Lab, Frederick, MD 21701 USA. NCI, Sci Applicat Int Corp, Target Struct Based Drug Discovery Grp, Frederick, MD 21701 USA.;Bavari, S, USA, Med Res Inst Infect Dis, 1425 Porter St, Ft Detrick, MD 21702 USA.;kelly.warfield@us.army.mil sina.bavari@us.army.mil
    1. Year: 2007
    2. Date: Nov
  2. Journal: Journal of Infectious Diseases
    1. 196
    2. Pages: S421-S429
  4. Type of Article: Article
  5. ISSN: 0022-1899
  1. Abstract:

    Background. Virus-like particles (VLPs) of Ebola virus (EBOV) and Marburg virus (MARV) produced in human 293T embryonic kidney cells have been shown to be effective vaccines against filoviral infection. In this study, we explored alternative strategies for production of filovirus-like particle-based vaccines, to accelerate the development process. The goal of this work was to increase the yield of VLPs, while retaining their immunogenic properties. Methods. Ebola and Marburg VLPs (eVLPs and mVLPs, respectively) were generated by use of recombinant baculovirus constructs expressing glycoprotein, VP40 matrix protein, and nucleoprotein from coinfected insect cells. The baculovirus-derived eVLPs and mVLPs were characterized biochemically, and then the immune responses produced by the eVLPs in insect cells were studied further. Results. The baculovirus-derived eVLPs elicited maturation of human myeloid dendritic cells (DCs), indicating their immunogenic properties. Mice vaccinated with insect cell-derived eVLPs generated antibody and cellular responses equivalent to those vaccinated with mammalian 293T cell-derived eVLPs and were protected from EBOV challenge in a dose-dependent manner. Conclusion. Together, these data suggest that filovirus-like particles produced by baculovirus expression systems, which are amenable to large-scale production, are highly immunogenic and are suitable as safe and effective vaccines for the prevention of filoviral infection.

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1086/520612
  3. View record in Web of Science®
  4. WOS: 000251090400042

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel